![Patric Trojer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Patric Trojer served as the Chief Scientific Officer at Constellation Pharmaceuticals, Inc. from 2018 to 2021.
Prior to that, he held other positions at the same company from 2008.
Trojer received a graduate and doctorate degree from the University of Innsbruck.
Anciens postes connus de Patric Trojer
| Sociétés | Poste | Fin |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 15/07/2021 |
Formation de Patric Trojer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
University of Innsbruck
 University of Innsbruck Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
